AB0855 BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS IN A PHASE 2 STUDY TO EVALUATE EFFICACY, SAFETY, AND TOLERABILITY OF MT-7117 IN SUBJECTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS - Khanna, D.; Carreira, P.; Chung, L.; Denton, C. P.; Matucci-Cerinic, M.; Riemekasten, G.; Mukai, S.; Liu, S.; Cai, S.; Bogoslovsky, T. (Annals of the rheumatic diseases, 2023)
Keywords: Age; Autoantibodies; Azathioprine; Clinical trials; Demographics; Demography; DNA-directed RNA polymerase; Endothelial cells; Fibrosis; Hydroxychloroquine; Immunological tolerance; Immunosuppressive agents; Inflammation; Melanocortin; Melanocyte-stimulating hormone; Methotrexate; Mycophenolic acid; Placebos; Randomized control trial; Rare/orphan diseases; Rheumatology; RNA polymerase; Scientific Abstracts; Scleroderma; Systemic sclerosis; Poland; North America; Europe